A Randomized, Multicenter, Open Label Study of MM-302 pl

Project: Research project

Project Details

Description

A Randomized, Multicenter, Open Label Study of MM-302 plus Trastuzumab vs. Chemotherapy of Physicians Choice plus Trastuzumab in Anthracycline Naive Patients with Locally Advanced/Metastatic HER2-Positive Breast Cancer
StatusFinished
Effective start/end date11/30/1411/30/19

Funding

  • Merrimack Pharmaceuticals, Inc

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.